Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC

EARLY_PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

July 31, 2024

Study Completion Date

December 31, 2025

Conditions

Non-small Cell Lung Cancer

Interventions

DRUG

Carboplatin

chemotherapy

DRUG

Paclitaxel

chemotherapy

RADIATION

70 Gy in 20 fractions over 4 weeks

accelerated hypofractionated RT

Trial Locations (1)

RECRUITING

SUNY Upstate Medical University, Syracuse

All Listed Sponsors

lead

State University of New York - Upstate Medical University

OTHER